Viewing Study NCT05411094


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-05-26 @ 5:07 AM
Study NCT ID: NCT05411094
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2022-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Pancreatic Carcinoma View
None Stage II Pancreatic Cancer AJCC v8 View
None Stage III Pancreatic Cancer AJCC v8 View
None Unresectable Pancreatic Carcinoma View
Keywords: